Pathology Today
Apr. 1, 2015

CAP response: JAMA breast biopsy study
College of American Pathologists
On March 17, the Journal of the American Medical Association published a study, "Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens," which examined pathologists' interpretations of breast biopsies. As the world's largest organization of board-certified pathologists, the CAP believes this article may lead to unnecessary worry for patients. More

How medical labs help physicians overcome the failure of many EHR systems to support effective lab test ordering and result reporting
Dark Daily
Most clinical laboratories and anatomic pathology groups would welcome a fast ("easy-on"), cheap and effective method that enables electronic lab test ordering and lab test reporting between physician's offices and medical laboratories. The goal is to create the seamless interface between the electronic health record systems of office-based physicians and the laboratory information systems of clinical laboratories. More

Obesity: The shocking numbers and new treatments
Obesity is on the rise worldwide. Every year, nearly 3 million people die of causes related to being overweight, victims of the lengthy lists of complications that can come with being obese — heart disease, stroke and diabetes among them. Data on obesity from around the world are worrisome, but a number of new treatments are already helping patients control their weight.More

Efforts to instill empathy among doctors are paying dividends
MedPage Today
Clinical empathy was once dismissively known as "good bedside manner" and traditionally regarded as far less important than technical acumen. But a spate of studies in the past decade has found that it is no mere frill. Increasingly, empathy is considered essential to establishing trust, the foundation of a good doctor-patient relationship. Studies have linked empathy to greater patient satisfaction, better outcomes, decreased physician burnout and a lower risk of malpractice suits and errors. More

Residency program aims to combat Florida doctor shortage
USA Today
A new medical residency program in southwest Florida aims to train young physicians as family practice doctors in an already medically under-served community, and ideally, persuade them to set up shop in the area once their residency is complete. As part of post-medical-school-training requirements, new doctors work for three years in hospitals and medical clinics to learn about medical specialties and to get a real-world education in treating patients. Doctors must successfully complete residency programs before they are free to practice on their own.More

Ovarian cancer treatment set to improve following biomarker discovery
Medical News Today
Resistance to chemotherapy is a major reason that patients with the most malignant form of ovarian cancer do not have a good chance of survival. Now researchers have discovered a biomarker that should improve prospects for patients by indicating how their bodies are likely to react to chemotherapy. More

Genomics needs a killer app
Genomics is an incredible technology for newborn and pre-natal screening, investigating the cause of a rare condition, and treating cancer, but for most healthy people it's still not particularly revolutionary. Imagine if instead, with the information locked in your DNA, we could predict what diseases you'll have and find effective and precise treatments, with no side-effects. What's standing between where we are now and that vision is a better understanding of DNA and what it means in the context of health and medicine.More

Kidney cancer detection: Simple urine test may become ideal diagnostic tool for disease
Medical Daily
Detecting kidney cancer in its early stage is an important aspect of treating the disease, but it only happens by chance during CT scans. In most cases, kidney masses found by CT Scans aren't even cancerous. A recent study conducted at Washington University School of Medicine in St. Louis has revealed that measuring certain protein biomarkers in urine samples is more than 95 percent accurate in identifying early-stage kidney cancer. More